Evidence map›Paper›PMID 37283741›Full record

ArticleFrontiers in immunology2023

Swine acute diarrhoea syndrome coronavirus (SADS-CoV) Nsp5 antagonizes type I interferon signaling by cleaving DCP1A.

Hai-Xin Huang, Chen-Chen Zhao, Xiao-Xiao Lei, Xin-Yu Zhang, Yu-Ying Li, Tian Lan, Bao-Peng Zhao, Jing-Yi Lu, Wen-Chao Sun, Hui-Jun Lu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Hai-Xin HuangCollege of Veterinary Medicine, Northwest A&F University, Xianyang, China.
Chen-Chen ZhaoInstitute of Virology, Wenzhou University, Wenzhou, China.
Xiao-Xiao LeiInstitute of Virology, Wenzhou University, Wenzhou, China.
Xin-Yu ZhangInstitute of Virology, Wenzhou University, Wenzhou, China.
Yu-Ying LiInstitute of Virology, Wenzhou University, Wenzhou, China.
Tian LanInstitute of Virology, Wenzhou University, Wenzhou, China.
Bao-Peng ZhaoInstitute of Virology, Wenzhou University, Wenzhou, China.
Jing-Yi LuInstitute of Virology, Wenzhou University, Wenzhou, China.
Wen-Chao SunInstitute of Virology, Wenzhou University, Wenzhou, China.
Hui-Jun LuChangchun Institute of Veterinary Medicine, Chinese Academy of Agricultural Sciences, Changchun, China.
Ning-Yi JinCollege of Veterinary Medicine, Northwest A&F University, Xianyang, China.
Wenzhou University · CNNorthwest A&F University · CNChinese Academy of Agricultural Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Swine acute diarrhoea syndrome coronavirus (SADS-CoV), which is a recently discovered enteric coronavirus, is the major aetiological agent that causes severe clinical diarrhoea and intestinal pathological damage in pigs, and it has caused significant economic losses to the swine industry. Nonstructural protein 5, also called 3C-like protease, cleaves viral polypeptides and host immune-related molecules to facilitate viral replication and immune evasion. Here, we demonstrated that SADS-CoV nsp5 significantly inhibits the Sendai virus (SEV)-induced production of IFN-β and inflammatory cytokines. SADS-CoV nsp5 targets and cleaves mRNA-decapping enzyme 1a (DCP1A) via its protease activity to inhibit the IRF3 and NF-κB signaling pathways in order to decrease IFN-β and inflammatory cytokine production. We found that the histidine 41 and cystine 144 residues of SADS-CoV nsp5 are critical for its cleavage activity. Additionally, a form of DCP1A with a mutation in the glutamine 343 residue is resistant to nsp5-mediated cleavage and has a stronger ability to inhibit SADS-CoV infection than wild-type DCP1A. In conclusion, our findings reveal that SADS-CoV nsp5 is an important interferon antagonist and enhance the understanding of immune evasion by alpha coronaviruses.

Indexed as

AlphacoronavirusCoronavirusInterferon Type IAnimalsEndopeptidasesSwineEndopeptidasesInterferon Type Iantiviral activityinterferon signalingmRNA-decapping enzyme 1a (DCP1A)nonstructural protein 5 (nsp5)swine acute diarrhoea syndrome coronavirus (SADS-CoV)

Identifiers

PMID37283741
PMCPMC10239798
OpenAlexW4377287326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.